Based in San Diego, Locanabio is built on the concept that gene therapy can deliver RNA-directed proteins to prevent or treat disease by targeting and modifying dysfunctional RNA . . .
Shooting the Messenger: Locanabio Writes a New Script for RNA Diseases
The San Diego start-up is creating a new class of gene therapies by targeting dysfunctional RNA
Source: David Bushnell, Ken Westover and Roger Kornberg, Stanford University
